A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Conditions: Pneumococcal Infectious Disease Interventions: Biological: Sinovac PCV13; Biological: PREVNAR 13 Sponsors: Sinovac Research and Development Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials